Skip to the page

Data / Form D filings / ALUMIS INC.

ALUMIS INC.: Form D filings

ALUMIS INC., a biotechnology company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on July 24, 2024, reports $40 million sold of a $40 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
280 EAST GRAND AVENUE, South San Francisco, CA, 94080
Phone
(650) 231-6625
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1847367

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 24, 2024New notice$40,000,000$40,000,0001Jul 17, 2024sec.gov
Mar 11, 2024New notice$258,999,914$129,499,957$129,499,95724Mar 4, 2024sec.gov
Mar 19, 2021New notice$60,000,000$60,000,0003Mar 4, 2021sec.gov
Feb 25, 2021New notice$10,500,000$10,500,0003Feb 12, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Srinivas R. AkkarajuDirector
John R. SchroerExecutive Officer
James B. TananbaumDirector
Derrick R. RichardsonExecutive Officer
Patrick B. MachadoDirector
Sapna B. SrivastavaDirector
Martin BablerExecutive Officer, Director
Mark BradleyExecutive Officer
Zhengbin B. YaoDirector
Sara R. KleinExecutive Officer
David M. GoldsteinExecutive Officer
Jorn DrappaExecutive Officer
Alan B. ColowickDirector
Roy C. HardimanExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ALUMIS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.